• Home
  • Editorial Board
  • Articles
    • Editorials
    • Guest Articles
  • News
    • Featured
    • Biotech News
  • Interviews
    • Interviews – Academia
    • Interviews – Industry
  • Issues – Archives
  • Subscribe
  • Contact
Facebook Twitter Instagram
Trending
  • Special Issue-Exclusive coverage of BRIC-NIAB
  • India’s Rare Disease updates by Prof. Ramaiah Muthyala
  • Indian Scientists published positive results of first in nation ‘Hemophilia A’ gene therapy
  • Unlocking the Potential: Microalgae as a Sustainable Aquafeed Ingredient
  • Indian scientists developed World’s only farmers’ suit “Kisan Kavach” which can protect them from harmful pesticides
  • 3 Nobel Prizes in 2024 went to biotech and allied scientists
  • USFDA approves Biocon Biologics’ biosimilar for Crohn’s disease, psoriasis
  • Dr. Soumya Swaminathan Honored with FABA Lifetime Achievement Award for Contributions to Global Health
Thursday, May 8
Facebook Twitter Instagram LinkedIn
Biotech Express
  • Home
  • Editorial Board
  • Articles
    • Editorials
    • Guest Articles
  • News
    • Featured
    • Biotech News
  • Interviews
    1. Interviews – Academia
    2. Interviews – Industry
    Featured
    04/01/20241

    Interview: Reach to common man is the heart and soul of India International Science Festival- Dr. Arvind C Ranade Chief Coordinator, IISF- 2023

    Recent
    04/01/2024

    Interview: Reach to common man is the heart and soul of India International Science Festival- Dr. Arvind C Ranade Chief Coordinator, IISF- 2023

    22/05/2023

    Prof Rajeev Varshney becomes the 4th Indian Agricultural Scientist to be elected as Fellow of the Royal Society

    26/07/2022

    We are making best hygiene solutions through Biotech applications: Dr Rachna Dave, founder MicroGO

  • Issues – Archives
  • Subscribe
  • Contact
Biotech Express
You are at:Home»Biotech News»Featured»Kenya National Biosafety Authority Approved GMO Cassava

Kenya National Biosafety Authority Approved GMO Cassava

0
By Biotech Express on 15/07/2021 Featured, Policies

On June 22, 2021, the Kenya National Biosafety Authority (NBA) approved the environmental release of genetically modified (GM) cassava event 4046, resistant to cassava brown streak disease (CBSD) developed by the Kenya Agricultural and Livestock Research Organization (KALRO).

The NBA Board approved the application as stated in the decision document dated June 16, 2021, following  the necessary review in accordance with the country’s Biosafety Act.

KALRO scientists have been developing CBSD-resistant cassava varieties using event 4046 under regulated confined field trial conditions authorized by NBA. The approval paves way for conducting national performance trials of these varieties before registration and release to farmers. The approval is valid for five (5) years from the date of authorization.
Cassava event 4046 was developed using modern biotechnology and was evaluated over a period of five years in confined field trials in three different locations in Kenya – Mtwapa (Kilifi), Kandara (Murang’a), and Alupe (Busia). It has shown high and stable resistance against CBSD, a disease that can result in a 100 percent loss of usable storage roots due to severe infection. The extensive review conducted by NBA confirms that GM cassava is as safe as conventional varieties for food, feed, and the environment.

The disease-resistant cassava was developed under the Virus Resistant Cassava for Africa Plus (VIRCA Plus) project, a collaborative program between KALRO, the National Crops Resources Research Institute of Uganda, and the Donald Danforth Plant Science Center.

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
Biotech Express
  • Website
  • Facebook
  • Twitter
  • LinkedIn

ISSN: 2454-6968 | Biotech Express Magazine publishes articles in the field of biotechnology and allied sciences in a way that have never been presented earlier. It publishes Editorials, Guest Articles, Reports, Interviews, Current News of Govt. Academics and Business, Research Highlights and Notifications of Events, Jobs, Research Proposals in the field of Biotechnology, Biological Sciences, Life Sciences, Microbiology, Biochemistry, Neurosciences, Genetics, Medical Sciences, BioPharma etc.

Related Posts

Indian Scientists published positive results of first in nation ‘Hemophilia A’ gene therapy

Dr. Soumya Swaminathan Honored with FABA Lifetime Achievement Award for Contributions to Global Health

Prof Rajeev Varshney, FRS ranked among world’s most impactful scholars Again

Leave A Reply Cancel Reply

Current Issue – January 2025
Biotech Express – e-ISSN: 2454-6968

Editorial Board

For Authors – Article Submission and Guidelines

Peer Review Policies

License and Copyright

Advertisement

Recent Posts
  • Special Issue-Exclusive coverage of BRIC-NIAB 15/02/2025
  • India’s Rare Disease updates by Prof. Ramaiah Muthyala 02/01/2025
  • Indian Scientists published positive results of first in nation ‘Hemophilia A’ gene therapy 28/12/2024
  • Unlocking the Potential: Microalgae as a Sustainable Aquafeed Ingredient 27/12/2024
  • Indian scientists developed World’s only farmers’ suit “Kisan Kavach” which can protect them from harmful pesticides 26/12/2024
  • 3 Nobel Prizes in 2024 went to biotech and allied scientists 13/12/2024
  • USFDA approves Biocon Biologics’ biosimilar for Crohn’s disease, psoriasis 01/12/2024
  • Dr. Soumya Swaminathan Honored with FABA Lifetime Achievement Award for Contributions to Global Health 23/11/2024
  • Scientists’ team led by Dr Tapan K Mondal claims Indian tea has independent origin after decoding its first ever Whole Genome 23/11/2024
  • Prof. K C Bansal Elected as a Fellow of The World Academy of Sciences (TWAS) 22/11/2024
Archives
Categories
  • Articles
  • Biotech News
  • Controversial
  • Editorials
  • Events
  • Featured
  • Guest Articles
  • Interviews
  • Interviews – Academia
  • Interviews – Industry
  • News-Industry
  • News-Research
  • Policies
  • SARS- CoV2 & COVID-19 Updates
  • Start-ups
About Us

About Biotech Express

Advisory and Editorial Board

Contact Us

Submission Policy and Guidelines

Submission policies

 

 

Follow us on Social Media
  • Facebook
  • Twitter
  • YouTube
We use cookies to help provide and enhance our service and tailor content and ads. By continuing you agree to the use of cookies. Copyright © 2013-2025 Biotech Express except certain content provided by third parties.

Type above and press Enter to search. Press Esc to cancel.